Loading company…
ID 405015353 · FY 2018–2021 · 4 years
კომპანიის ძირითად საქმიანობას წარმოადგენს წარმოადგენს სამედიცინო პრეპარატის წარმოებას და რეალიზაციას.
Bars are revenue on the left axis; lines are EBITDA and net margin on the right.
| Line item | 2018 | 2019 | 2020 | 2021 | CAGR |
|---|---|---|---|---|---|
| Total Revenue | 2,225 | 1,070 | 2,524 | 594 | -35.6% |
| Total COGS | -1,675 | -873 | -2,375 | -478 | -34.2% |
| Gross Profit | 550 | 197 | 149 | 116 | -40.4% |
| Gross Margin | 24.7% | 18.4% | 5.9% | 19.6% | |
| Total Operating Expenses | -169 | -342 | -336 | -440 | +37.4% |
| EBITDA | 380 | -145 | -187 | -323 | nmf |
| EBITDA Margin | 17.1% | -13.6% | -7.4% | -54.4% | |
| Total D&A | 0 | 0 | -0 | -0 | -11.1% |
| EBIT / Operating Income | 380 | -145 | -188 | -324 | nmf |
| Total Interest Income | 21 | 0 | 0 | 0 | |
| Total Interest Expense | 0 | -38 | 0 | 0 | |
| Total Other Income | -14 | 144 | -25 | 260 | nmf |
| Profit Before Tax | 388 | -40 | -213 | -64 | nmf |
| Total Income Tax | 0 | 0 | 0 | 0 | |
| Net Profit / (Loss) | 363 | -40 | -213 | -64 | nmf |
| Net Margin | 16.3% | -3.7% | -8.4% | -10.7% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Companies sharing this sub-sector, ranked by how close their latest revenue is to this one — not a curated comp set.